Discipline of Biomedical Science and Brain and Mind Centre, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia; Department of Pathology, The University of Melbourne, Parkville, VIC 3052, Australia.
Cell Chem Biol. 2018 Jul 19;25(7):807-816. doi: 10.1016/j.chembiol.2018.05.004. Epub 2018 May 31.
Shared molecular pathologies between distinct neurodegenerative disorders offer unique opportunities to identify common mechanisms of neuron death, and apply lessons learned from one disease to another. Neurotoxic superoxide dismutase 1 (SOD1) proteinopathy in SOD1-associated familial amyotrophic lateral sclerosis (fALS) is recapitulated in idiopathic Parkinson disease (PD), suggesting that these two phenotypically distinct disorders share an etiological pathway, and tractable therapeutic target(s). Despite 25 years of research, the molecular determinants underlying SOD1 misfolding and toxicity in fALS remain poorly understood. The absence of SOD1 mutations in PD highlights mounting evidence that SOD1 mutations are not the sole cause of SOD1 protein misfolding occasioning oligomerization and toxicity, reinforcing the importance of non-genetic factors, including protein metallation and post-translational modification in determining SOD1 stability and function. We propose that these non-genetic factors underlie the misfolding and dysfunction of SOD1 and other proteins in both PD and fALS, constituting a shared and tractable pathway to neurodegeneration.
不同神经退行性疾病之间存在共享的分子病理学,这为鉴定神经元死亡的共同机制提供了独特的机会,并可以将从一种疾病中获得的经验教训应用于另一种疾病。SOD1 相关家族性肌萎缩侧索硬化症 (fALS) 中的神经毒性超氧化物歧化酶 1 (SOD1) 蛋白病在特发性帕金森病 (PD) 中得到重现,这表明这两种表型截然不同的疾病具有共同的发病机制和可治疗的靶点。尽管进行了 25 年的研究,但 fALS 中 SOD1 错误折叠和毒性的分子决定因素仍知之甚少。PD 中不存在 SOD1 突变,这突显了越来越多的证据表明 SOD1 突变并非导致 SOD1 蛋白错误折叠、寡聚化和毒性的唯一原因,这进一步强调了非遗传因素(包括蛋白质金属化和翻译后修饰)在决定 SOD1 稳定性和功能方面的重要性。我们提出,这些非遗传因素是 PD 和 fALS 中 SOD1 和其他蛋白质错误折叠和功能障碍的基础,构成了一个共同的、可治疗的神经退行性变途径。